Personalized laboratory medicine

Results of an european survey conducted by the EFLM/ESPT WG-PLM

M. Pazzagli, F. Malentacchi, I. Mancini, I. Brandslund, P. Vermeersch, M. Schwab, J. Marc, E. Theodorsson, R. Van Schaik, C. Di Resta

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Resumé

Developments in "omics" are creating a paradigm shift in Laboratory Medicine leading to Personalised Medicine. This allows the increasing in diagnostics and therapeutics focused on individuals rather than populations. In order to investigate whether Laboratory Medicine is able to implement new diagnostic tools and expertise and commands proper state-of-the-art knowledge about Personalized Medicine and Laboratory Medicine in Europe, the joint Working Group "Personalized Laboratory Medicine" of the EFLM and ESPT societies compiled and conducted the Questionnaire "Is Laboratory Medicine ready for the era of Personalized Medicine?". 48 laboratories from 18 European countries participated at this survey. The answers of the participating Laboratory Medicine professionals indicate that they are aware that Personalized Medicine can represent a new and promising health model. Whereas they are aware that Laboratory Medicine should play a key role to support the implementation of Personalized Medicine in the clinical settings, the participants of this survey think that the current organization of the Laboratory Medicine needs additional/relevant implementations such as: 1. New technological Facilities in "omics"; 2. Additional training for the current personnel focused on the new methodologies; 3. Incorporation in the Laboratory of new competencies in data interpretation and counselling; 4. Improving cooperation and collaboration between professionals of different disciplines to integrate information suitable for a Personalized Medicine approach. This survey suggest a strategic plan that should be considered by both health care providers and scientific societies of Laboratory Medicine. The implementation of Personalized Medicine should be first tested in a limited number of centers (Academic / Hospitals) possessing a wide range of competencies and facilities in "-omics" and in bioinformatics. These centers should then be supported to gain the missing technological facilities and appropriately trained for this aim.
OriginalsprogEngelsk
TidsskriftClinical Chemistry and Laboratory Medicine
Vol/bind53
Udgave nummerS1
Sider (fra-til)S24
Antal sider1
ISSN1434-6621
StatusUdgivet - 2015
Begivenhed 21st IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine - Paris, Frankrig
Varighed: 21. jun. 201525. jun. 2015

Konference

Konference 21st IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine
LandFrankrig
ByParis
Periode21/06/201525/06/2015

Emneord

  • *European *laboratory *clinical chemistry personalized medicine human diagnosis model health questionnaire organization bioinformatics health care organization personnel Europe health care personnel counseling methodology hospital population therapy

Citer dette

Pazzagli, M., Malentacchi, F., Mancini, I., Brandslund, I., Vermeersch, P., Schwab, M., ... Di Resta, C. (2015). Personalized laboratory medicine: Results of an european survey conducted by the EFLM/ESPT WG-PLM. Clinical Chemistry and Laboratory Medicine, 53(S1), S24.
Pazzagli, M. ; Malentacchi, F. ; Mancini, I. ; Brandslund, I. ; Vermeersch, P. ; Schwab, M. ; Marc, J. ; Theodorsson, E. ; Van Schaik, R. ; Di Resta, C. / Personalized laboratory medicine : Results of an european survey conducted by the EFLM/ESPT WG-PLM. I: Clinical Chemistry and Laboratory Medicine. 2015 ; Bind 53, Nr. S1. s. S24.
@article{b3d62014c2784850ad12062474715469,
title = "Personalized laboratory medicine: Results of an european survey conducted by the EFLM/ESPT WG-PLM",
abstract = "Developments in {"}omics{"} are creating a paradigm shift in Laboratory Medicine leading to Personalised Medicine. This allows the increasing in diagnostics and therapeutics focused on individuals rather than populations. In order to investigate whether Laboratory Medicine is able to implement new diagnostic tools and expertise and commands proper state-of-the-art knowledge about Personalized Medicine and Laboratory Medicine in Europe, the joint Working Group {"}Personalized Laboratory Medicine{"} of the EFLM and ESPT societies compiled and conducted the Questionnaire {"}Is Laboratory Medicine ready for the era of Personalized Medicine?{"}. 48 laboratories from 18 European countries participated at this survey. The answers of the participating Laboratory Medicine professionals indicate that they are aware that Personalized Medicine can represent a new and promising health model. Whereas they are aware that Laboratory Medicine should play a key role to support the implementation of Personalized Medicine in the clinical settings, the participants of this survey think that the current organization of the Laboratory Medicine needs additional/relevant implementations such as: 1. New technological Facilities in {"}omics{"}; 2. Additional training for the current personnel focused on the new methodologies; 3. Incorporation in the Laboratory of new competencies in data interpretation and counselling; 4. Improving cooperation and collaboration between professionals of different disciplines to integrate information suitable for a Personalized Medicine approach. This survey suggest a strategic plan that should be considered by both health care providers and scientific societies of Laboratory Medicine. The implementation of Personalized Medicine should be first tested in a limited number of centers (Academic / Hospitals) possessing a wide range of competencies and facilities in {"}-omics{"} and in bioinformatics. These centers should then be supported to gain the missing technological facilities and appropriately trained for this aim.",
keywords = "*European *laboratory *clinical chemistry personalized medicine human diagnosis model health questionnaire organization bioinformatics health care organization personnel Europe health care personnel counseling methodology hospital population therapy",
author = "M. Pazzagli and F. Malentacchi and I. Mancini and I. Brandslund and P. Vermeersch and M. Schwab and J. Marc and E. Theodorsson and {Van Schaik}, R. and {Di Resta}, C.",
year = "2015",
language = "English",
volume = "53",
pages = "S24",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walterde Gruyter GmbH",
number = "S1",

}

Pazzagli, M, Malentacchi, F, Mancini, I, Brandslund, I, Vermeersch, P, Schwab, M, Marc, J, Theodorsson, E, Van Schaik, R & Di Resta, C 2015, 'Personalized laboratory medicine: Results of an european survey conducted by the EFLM/ESPT WG-PLM', Clinical Chemistry and Laboratory Medicine, bind 53, nr. S1, s. S24.

Personalized laboratory medicine : Results of an european survey conducted by the EFLM/ESPT WG-PLM. / Pazzagli, M.; Malentacchi, F.; Mancini, I.; Brandslund, I.; Vermeersch, P.; Schwab, M.; Marc, J.; Theodorsson, E.; Van Schaik, R.; Di Resta, C.

I: Clinical Chemistry and Laboratory Medicine, Bind 53, Nr. S1, 2015, s. S24.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

TY - ABST

T1 - Personalized laboratory medicine

T2 - Results of an european survey conducted by the EFLM/ESPT WG-PLM

AU - Pazzagli, M.

AU - Malentacchi, F.

AU - Mancini, I.

AU - Brandslund, I.

AU - Vermeersch, P.

AU - Schwab, M.

AU - Marc, J.

AU - Theodorsson, E.

AU - Van Schaik, R.

AU - Di Resta, C.

PY - 2015

Y1 - 2015

N2 - Developments in "omics" are creating a paradigm shift in Laboratory Medicine leading to Personalised Medicine. This allows the increasing in diagnostics and therapeutics focused on individuals rather than populations. In order to investigate whether Laboratory Medicine is able to implement new diagnostic tools and expertise and commands proper state-of-the-art knowledge about Personalized Medicine and Laboratory Medicine in Europe, the joint Working Group "Personalized Laboratory Medicine" of the EFLM and ESPT societies compiled and conducted the Questionnaire "Is Laboratory Medicine ready for the era of Personalized Medicine?". 48 laboratories from 18 European countries participated at this survey. The answers of the participating Laboratory Medicine professionals indicate that they are aware that Personalized Medicine can represent a new and promising health model. Whereas they are aware that Laboratory Medicine should play a key role to support the implementation of Personalized Medicine in the clinical settings, the participants of this survey think that the current organization of the Laboratory Medicine needs additional/relevant implementations such as: 1. New technological Facilities in "omics"; 2. Additional training for the current personnel focused on the new methodologies; 3. Incorporation in the Laboratory of new competencies in data interpretation and counselling; 4. Improving cooperation and collaboration between professionals of different disciplines to integrate information suitable for a Personalized Medicine approach. This survey suggest a strategic plan that should be considered by both health care providers and scientific societies of Laboratory Medicine. The implementation of Personalized Medicine should be first tested in a limited number of centers (Academic / Hospitals) possessing a wide range of competencies and facilities in "-omics" and in bioinformatics. These centers should then be supported to gain the missing technological facilities and appropriately trained for this aim.

AB - Developments in "omics" are creating a paradigm shift in Laboratory Medicine leading to Personalised Medicine. This allows the increasing in diagnostics and therapeutics focused on individuals rather than populations. In order to investigate whether Laboratory Medicine is able to implement new diagnostic tools and expertise and commands proper state-of-the-art knowledge about Personalized Medicine and Laboratory Medicine in Europe, the joint Working Group "Personalized Laboratory Medicine" of the EFLM and ESPT societies compiled and conducted the Questionnaire "Is Laboratory Medicine ready for the era of Personalized Medicine?". 48 laboratories from 18 European countries participated at this survey. The answers of the participating Laboratory Medicine professionals indicate that they are aware that Personalized Medicine can represent a new and promising health model. Whereas they are aware that Laboratory Medicine should play a key role to support the implementation of Personalized Medicine in the clinical settings, the participants of this survey think that the current organization of the Laboratory Medicine needs additional/relevant implementations such as: 1. New technological Facilities in "omics"; 2. Additional training for the current personnel focused on the new methodologies; 3. Incorporation in the Laboratory of new competencies in data interpretation and counselling; 4. Improving cooperation and collaboration between professionals of different disciplines to integrate information suitable for a Personalized Medicine approach. This survey suggest a strategic plan that should be considered by both health care providers and scientific societies of Laboratory Medicine. The implementation of Personalized Medicine should be first tested in a limited number of centers (Academic / Hospitals) possessing a wide range of competencies and facilities in "-omics" and in bioinformatics. These centers should then be supported to gain the missing technological facilities and appropriately trained for this aim.

KW - European laboratory clinical chemistry personalized medicine human diagnosis model health questionnaire organization bioinformatics health care organization personnel Europe health care personnel counseling methodology hospital population therapy

M3 - Conference abstract in journal

VL - 53

SP - S24

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - S1

ER -